4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Cardio Diagnostics Holdings, Inc. (CDIO) operates in the Biotechnology industry and is headquartered in Chicago, United States with about 15 employees. Its market capitalization is roughly $5 million. In the fiscal year ended 2025-12-31, CDIO reported $0M in revenue and ($6M) in net income.
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease.
Interactive charts & full statements → Open the CDIO valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($6M) | ($8M) | ($7M) | ($4M) | — |
| Net Income | ($6M) | ($8M) | ($8M) | ($5M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($2M) | ($2M) | ($2M) | ($2M) | ($2M) | — |
| Net Income | ($2M) | ($2M) | ($2M) | ($2M) | ($2M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $8M | $11M | $4M | $6M | — |
| Total Liabilities | $1M | $1M | $2M | $2M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CDIO viewer.
About TickerBase · Data methodology & sources